SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0000950123-11-067012
Filing Date
2011-07-21
Accepted
2011-07-21 08:00:26
Documents
6
Period of Report
2011-07-15
Filing Date Changed
2011-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c20095e8vk.htm 8-K 21709
2 EXHIBIT 10.1 c20095exv10w1.htm EX-10.1 44308
3 EXHIBIT 10.2 c20095exv10w2.htm EX-10.2 63698
4 EXHIBIT 10.3 c20095exv10w3.htm EX-10.3 18935
5 EXHIBIT 10.4 c20095exv10w4.htm EX-10.4 24424
6 EXHIBIT 99.1 c20095exv99w1.htm EX-99.1 5905
  Complete submission text file 0000950123-11-067012.txt   180502
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

IRS No.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-52530 | Film No.: 11978735
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1